Financial News
Immatics N.V. - Ordinary Shares (NQ:IMTX)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 4.260 |
| Bid (Size) | 4.260 (4) |
| Ask (Size) | 4.360 (5) |
| Prev. Close | 4.260 |
| Today's Range | 4.260 - 4.260 |
| 52wk Range | 3.300 - 13.77 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 03, 2025
Performance
More News
Read More
Immatics Announces Pricing of $150 Million Public Offering
October 10, 2024
Why Is Cancer-Focused Immatics Stock Trading Lower On Thursday?
October 10, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 10, 2024
Immatics Announces Proposed $150 Million Public Offering
October 10, 2024
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
October 01, 2024
Immatics Appoints Alise Reicin to Board of Directors
July 31, 2024
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2024
Immatics Announces Pricing of $175 Million Public Offering
January 17, 2024
Frequently Asked Questions
Is Immatics N.V. - Ordinary Shares publicly traded?
Yes, Immatics N.V. - Ordinary Shares is publicly traded.
What exchange does Immatics N.V. - Ordinary Shares trade on?
Immatics N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Immatics N.V. - Ordinary Shares?
The ticker symbol for Immatics N.V. - Ordinary Shares is IMTX on the Nasdaq Stock Market
What is the current price of Immatics N.V. - Ordinary Shares?
The current price of Immatics N.V. - Ordinary Shares is 4.260
When was Immatics N.V. - Ordinary Shares last traded?
The last trade of Immatics N.V. - Ordinary Shares was at 04/17/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
